An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity

被引:166
作者
Parsons, JT [1 ]
Mendenhall, WM [1 ]
Stringer, SP [1 ]
Cassisi, NJ [1 ]
Million, RR [1 ]
机构
[1] UNIV FLORIDA,DEPT OTOLARYNGOL,COLL MED,GAINESVILLE,FL 32610
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 39卷 / 01期
关键词
mouth neoplasms; radiotherapy; squamous cell carcinoma; surgery; treatment outcome;
D O I
10.1016/S0360-3016(97)00152-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To analyze factors influencing outcome in patients who received postoperative irradiation for advanced squamous cell carcinoma of the oral cavity. Methods and Materials: Between October 1964 and November 1993, 134 patients with 135 previously untreated primary invasive squamous cell carcinomas of the oral cavity (excluding the lip) were treated postoperatively with continuous courses of external-beam irradiation at the University of Florida. All patients had a minimum follow-up of 2 years (analysis, December 1995). No patient was lost to follow-up. Results: The 10-year actuarial rates of primary site, neck, and local-regional control were 79%, 88%, and 71%, respectively. Recurrence of cancer above the clavicles developed in 35 patients. Ninety-four percent of the recurrences were within the primary field of irradiation (anterior to the plane of the spinal cord); there were 24 recurrences at the primary site and nine in the upper neck alone. There were no failures in the neck area behind the plane of the spinal cord (i.e., the ''posterior strip''). Two failures occurred in the low neck below the level of the thyroid notch. In univariate analyses, factors that affected local-regional control included pathologic stage (I-II vs. III-IV, p = 0.04), margin status (invasive cancer at the margin vs. other,p = 0.0007),multifocal tumor(p = 0.05), perineural invasion (p = 0.04), and number of indications for postoperative irradiation (p = 0.05). Extracapsular nodal extension was marginally significant (p = 0.07). In multivariate analysis, positive margins and number of indications remained significant. These factors were used to define relatively favorable (< 4 indications, margins not positive) and unfavorable (greater than or equal to 4 indications and/or margins positive for invasive cancer) groups. For both favorable and unfavorable groups, there were nonsignificant trends toward improved local-regional control for patients who began irradiation within 45-50 days, compared with those whose irradiation began later. There were also nonsignificant trends toward improved control for patients treated with shorter overall irradiation treatment courses. An analysis was also performed on the effects of duration of the overall ''treatment package'' (from the date of surgery until the lest day of irradiation). For patients with unfavorable tumors, there was a significantly higher probability of local-regional control for patients whose overall ''treatment package'' was less than or equal to 100 days (60% vs. 14%,p = 0.04). The 5-year rate of distant metastasis as the sole site of failure was 8% and was predicted by pathologic N stage (NO-NI, 3%; N2-N3, 16%,p = 0.02), as well as the presence (20%) or absence (6%) of extracapsular nodal extension (p = 0.06). The 5-year freedom-from-relapse rate was 63%. The 5-year survival and cause-specific survival rates were 50% and 67%, respectively. Four severe radiation injuries occurred (3%). Conclusion: This paper provides data that define relatively favorable and unfavorable groups of patients in the postoperative setting. Patients with four or more indications for irradiation and/or invasive cancer at the surgical margins have a worse outcome than patients who do not have these negative factors; this is true in spite of the fact that the unfavorable group received higher doses of radiation. Attention should be focused on not only the interval between surgery and irradiation, but also time-dose parameters and the overall duration of the treatment ''package.'' (C) 1997 Elsevier Science Inc.
引用
收藏
页码:137 / 148
页数:12
相关论文
共 50 条
  • [21] Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma
    Xiang, Michael
    Holsinger, Floyd Christopher
    Gensheimer, Michael F.
    Divi, Vasu
    Pollom, Erqi L.
    Colevas, Alexander Dimitrios
    Le, Quynh-Thu
    Beadle, Beth M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (03): : 99 - 104
  • [22] Intensity-modulated radiotherapy improves outcomes in postoperative patients with squamous cell carcinoma of the oral cavity
    Chen, Pang-Yu
    Chen, Helen H. W.
    Hsiao, Jenn-Ren
    Yang, Ming-Wei
    Hsueh, Wei-Ting
    Tasi, Sen-Tien
    Lin, Forn-Chia
    Wu, Yuan-Hua
    ORAL ONCOLOGY, 2012, 48 (08) : 747 - 752
  • [23] Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma
    Darragh S. Gogarty
    Paul Lennon
    Sandra Deady
    J. Barry O’Sullivan
    Orla McArdle
    Mary Leader
    Patrick Sheahan
    James Paul O’Neill
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 953 - 960
  • [24] Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: The importance of the overall treatment time
    Langendijk, JA
    de Jong, MA
    Leemans, CR
    de Bree, R
    Smeele, LE
    Doornaert, P
    Slotman, BJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03): : 693 - 700
  • [25] Socioeconomic Status, Length of Stay, and Postoperative Complications in Oral Cavity Squamous Cell Carcinoma
    Xie, Michael
    Staibano, Phillip
    Gupta, Michael K.
    Nguyen, Nhu Tram
    Archibald, Stuart D.
    Jackson, Bernard Stanley
    Young, James Edward Massey
    Zhang, Han
    ENT-EAR NOSE & THROAT JOURNAL, 2024,
  • [26] Postoperative Radiotherapy for Patients at High Risk of Recurrence of Oral Cavity Squamous Cell Carcinoma
    Herman, Michael P.
    Dagan, Roi
    Amdur, Robert J.
    Morris, Christopher G.
    Werning, John W.
    Vaysberg, Mikhail
    Mendenhall, William M.
    LARYNGOSCOPE, 2015, 125 (03) : 630 - 635
  • [27] Lip and Oral Cavity Squamous Cell Carcinoma
    Howard, Adam
    Agrawal, Nishant
    Gooi, Zhen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (05) : 895 - 911
  • [28] The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database
    Barrett, Thomas F.
    Mazul, Angela L.
    Stepan, Katelyn O.
    Wood, C. Burton
    Paniello, Randall C.
    Zevallos, Jose P.
    Massa, Sean
    Jackson, Ryan S.
    Schmitt, Nicole C.
    Zenga, Joseph
    Kang, Stephen Y.
    Pipkorn, Patrik
    Rich, Jason T.
    Puram, Sidharth, V
    ORAL ONCOLOGY, 2021, 118
  • [29] SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY
    Leu, Yi-Shing
    Chang, Yi-Fang
    Lee, Jehn-Chuan
    Liu, Chung-Ji
    Hsiao, Hung-Tao
    Chen, Yu-Jen
    Chen, Hong-Wen
    Lin, Ya-Ping
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2009, 3 (01) : 75 - 80
  • [30] Historical compliance rates for providing postoperative radiotherapy in oral cavity squamous cell carcinoma
    Hinther, Ashley
    Nakoneshny, Steven C.
    Dort, Joseph C.
    Chandarana, Shamir P.
    Matthews, T. Wayne
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (10): : 1525 - 1529